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Abstract Hip fracture is a common physical trauma
in older adults that is also associated with a high
incidence of new onset depression. The immune
system declines with age and is also compromised
by physical and psychological stress. This study
examined whether hip fracture and depressive symp-
toms had additive effects upon the aged immune
system that might contribute to poor health outcomes
after hip fracture. We assessed the frequency of
regulatory T cells, Tregs (CD4
? CD25? Foxp3?) and
IL10 production by CD4 T cells, and the frequency
and IL10 production by regulatory B cells, Bregs
(CD19? CD24hi CD38hi) in 101 hip fracture patients
(81 female) 6 weeks after injury and 43 healthy age-
matched controls (28 female). 38 hip fracture patients
(37 %) developed depressive symptoms. Hip fracture
did not have an effect on circulating Tregs frequency
but a significant reduction in the frequency of Bregs
was observed in patients who developed depression
compared with non-depressed patients (p = 0.001) or
healthy controls (p\ 0.001). Bregs also showed a
significant decline in IL10 production in depressed hip
fracture patients compared with controls (p = 0.04)
and non-depressed patients (p = 0.01). In contrast,
there was an increase in IL10 production by CD4 T
cells in hip fracture patients with new onset depression
compared to hip fracture patients without depression
(p = .04) and healthy controls (p = .02). We con-
clude that the reduced immunity associated with new
onset depression post hip fracture could include a
contribution by heightened Tregs function.
Keywords Hip fracture  Depression  Regulatory T
cell  Regulatory B cell  Stress  Immunesenescence
Introduction
Hip fracture is a common and devastating injury and a
major health issue in old age (Abrahamsen et al. 2009).
1 in 3 adults aged 65 years and over fall each year and
in the UK alone this results in approximately 75,000
hip fractures each year. Hip fracture is a frequent cause
of institutionalisation and has a 1 year mortality of
approximately 25 % (Panula et al. 2011) with infec-
tions a major cause of morbidity and mortality in this
patient group (Edwards et al. 2008). The reasons for
such poor outcomes in this trauma population are
multifactorial but include co-morbidities (Edwards
et al. 2008; Panula et al. 2011), reduced immunity
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(Butcher et al. 2005) and the consequences of
depression (Phillips et al. 2013). Healthy older indi-
viduals have been reported to experience greater levels
of stress, anxiousness and depression than young
adults (Luz et al. 2003). Stressful life events such as
bereavement or a disabling medical event are amongst
the most potent factors that can trigger depressive
symptoms (Cole and Dendukuri 2003). Therefore, it is
perhaps not surprising that a high rate of depression
(9–47 %) has been reported in studies of older adults
with hip fracture (Holmes and House 2000). Impor-
tantly, depression in hip fracture patients has been
associated with increased risk of infections and poor
survival (Nightingale et al. 2001), impaired recovery
and a retarded ability to regain pre-fracture levels of
physical functioning (Mossey et al. 1990).
It is well documented that ageing is accompanied
by immune decline, termed immunesenescence,
which contributes to increased susceptibility to infec-
tions in older adults (Dorshkind et al. 2009; Panda
et al. 2009). However the immune system does not act
in isolation and is profoundly affected by both
physical and psychological stress (Butcher and Lord
2004; Segerstrom andMiller 2004). Importantly, there
is accumulating evidence suggesting that the effects of
stress and age are interactive, with chronic stress
exacerbating the effects of ageing in older adults
(Kiecolt-Glaser and Glaser 1999). In this study we set
out to test the hypothesis that psychological stress,
specifically depressive symptoms, would act addi-
tively with the physical stress of hip fracture to
amplify the effect of ageing upon immunity. We have
reported previously that after hip fracture the function
of innate immune cells (neutrophils, NK cells and
monocytes) was significantly suppressed but only in
the patients who developed depression (Duggal et al.
2013a, 2014, 2015). Here we extend the investigation
to consider the regulatory cells of the immune system
that are central to immune homeostasis, in order to
determine if over activity in this arm of the immune
response to injury could account for reduced immunity
and increased susceptibility to infections after hip
fracture.
Once activated it is essential to modulate the
immune response to prevent unintended harmful
effects arising from the defensive actions of immune
cells. Regulatory CD4?CD25?Foxp3? T cells play a
pivotal role in maintaining immune homeostasis by
suppressing immune responses (Wing and Sakaguchi
2010). Tregs suppressive function is mediated via
production of immunosuppressive cytokines, such as
IL10 (Hara et al. 2001), TGFb (Oida et al. 2003) and
via cell–cell contact (Stephens et al. 2001). An age
associated increase in the frequency of Tregs has been
reported in mice (Kozlowska et al. 2007; Zhao et al.
2007) and humans (Gregg et al. 2005). However,
concomitant impairment in the immunosuppressive
function of CD4? Tregs has been shown in aged mice
(Zhao et al. 2007) and humans (Tsaknaridis et al.
2003), though the literature is inconsistent with other
studies reporting intact Tregs suppressive function with
age (Gregg et al. 2005; Lages et al. 2008). More
recently, a subset of B cells has been shown to be able
to suppress inflammation (Wolf et al. 1996). In
humans, CD19?CD24hi CD38hi immature transitional
B cells exhibit immunosuppressive properties, mainly
via IL10 production on stimulation via CD40 or the
TLR pathway (Blair et al. 2010; Duggal et al. 2013b).
These IL10 producing B cells restrain inflammatory
Th1 and Th17 cells and maintain Treg numbers (Carter
et al. 2012; 2011). Tedder and co-workers have also
reported the existence of a CD19? CD5? CD1dhi B
cell subset, designated as B10 cells that can exert
immunosuppressive effects in a IL10 dependent
manner (Yanaba et al. 2008). Recently on investigat-
ing regulatory function in healthy older adults we
reported both numerical and functional impairments
(reduced IL10 production) in CD19? CD24hi CD38hi
Bregs with advancing age (Duggal et al. 2013b) .
Here we investigated the impact of hip fracture and
new onset depressive symptoms on the frequency and
function of Tregs and CD19
? CD24hi CD38hi B cells.
Materials and methods
Study participants
101 older hip fracture patients were recruited from five
hospitals in Birmingham, UK between 2010 and 2012.
Inclusion criteria were that participants had to be aged
60 years and over with a hip fracture sustained
4–6 weeks previously but with no chronic immune-
related disorders or taking any regular medications
that might modify immunity. Additionally patients
must not have had any diagnosis of depression by a
physician prior to age 50 years or be taking or have
previously taken anti-depressant medication. 43
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healthy older adults were also recruited from the
community as controls. These controls also had to
meet the inclusion criteria above but not have had a hip
fracture. The study was approved by South Birming-
ham Local Research Ethics Committee and all partic-
ipants provided written informed consent (study ref:
09/H1203/80).
Study design and procedure
The study was a prospective case–control design with
three groups of older adults: hip fracture patients with
or without depressive symptoms and healthy older
adults. Consent was gained whilst patients were still in
hospital. All patients provided a blood sample and
completed questionnaires and structured interviews
4-6 weeks after hip fracture. Control participants
attended the University, for one-off blood sampling
and completed questionnaires. None of the partici-
pants had an acute infection at the time of blood
sampling.
Assessment for depressive symptoms
Standard socio-demographic and health behaviour
information were taken and all comorbidities and
medications, prescription and over-the-counter, were
recorded by the interviewer. The psychological status
of the participant was assessed by a Geriatric Depres-
sion Scale (GDS) (Yesavage et al. 1982). Depression
was defined as a GDS score greater than or equal to
six. The Hospital Anxiety and Depression Scale
(HADS) was also used to measure depression and
anxiety (Zigmond and Snaith 1983). Healthy control
participants completed the HADS depression sub-
scale in order to check that they did not have
significant depressive symptoms.
Foxp3 staining for identification of Tregs
Peripheral blood mononuclear cells (PBMCs) were
isolated by density centrifugation using Ficoll-
PaqueTM PLUS (GE Healthcare, Sweden). Isolated
PBMCs were resuspended in phosphate buffered
saline (PBS) at a concentration of 1 9 106/ml and
were stained with anti-human CD3-PEcy7 (eBio-
sciences, UK; clone: UCHT1), anti-human CD4 Alexa
fluor 450 (eBiosciences, UK; clone: RPA-T4) and
anti-human CD25 APC (Biolegend, UK; clone: BC96)
antibodies for 20 min in the dark at 4 C. Post
incubation, cells were washed with PBS and re-
suspended in Foxp3 Fix Perm Working solution
(eBiosciences, UK) and incubated for 30 min in the
dark at room temperature. Post incubation, cells were
washed and resuspended in Foxp3 Permeabilization
buffer (eBiosciences, UK) and stained with anti-
human Foxp3 PE antibody (eBiosciences, UK) for
30 min in the dark at room temperature. Finally, the
cells were washed and resuspended in PBS for flow
cytometric analysis using a Cyan TM ADP (Dako Ltd,
UK). The percentage of CD3? CD4? CD25? Foxp3?
T cells were recorded.
Stimulation of PBMCs to induce IL10 production
by CD4 T cells
Cell cultures were performed in RPMI 1640 (Sigma
Aldrich, UK) containing 10 % FCS (Biosera, UK)
supplemented with glutamine/penicillin/streptomycin
(Life Technologies, UK). PBMCs (1 9 106/ml) were
stimulated for 4 h with PMA (50 ng/ml; Sigma
Aldrich, UK) and Ionomycin (500 ng/ml; Sigma
Aldrich, UK) in the presence of Brefeldin A (10 lg/
ml; Sigma Aldrich, UK). Post stimulation, cells were
washed twice with PBS and stained using anti-human
CD3 PEcy7 (eBiosciences, UK; clone: UCHT1) and
anti-human CD4 Alexa fluor 450 (eBiosciences, UK;
clone: RPA-T4) for 20 min in the dark at 4 C. Cells
were washed and fixed with Reagent A (Fix and Perm
kit, Invitrogen, UK) for 30 min in the dark at room
temperature. Post incubation, cells were washed and
re-suspended in Reagent B (Fix and Perm kit,
Invitrogen, UK) and anti-human Alexa fluor 647
IL10 antibody (clone: JES3-9D7) was added to cells
that were incubated in the dark at room temperature
for 30 min. After washing the cells were resuspended
in PBS and analysed on a Cyan TM ADP (Dako Ltd,
UK) and the percentage of CD3? CD4? IL10? T cells
and IL10 expression levels (MFI value) by CD4 T
cells was recorded.
Identification of immunosuppressive
CD19?CD24hiCD38hi B cells
Isolated PBMCs (1 9 106/ml) were stained with a
combination of fluorochrome conjugated antibodies
including; CD19-PE (eBiosciences, clone: HIB19),
CD24-FITC (eBiosciences, clone: eBioSN3), CD38-
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PEcy7 (eBiosciences, clone: HIT2), antibodies for
20 min in dark at 4 C. Post incubation, the cells were
washed and resuspended in PBS for flow cytometric
analysis using Cyan TM ADP (Dako Ltd, UK). The
percentage of CD24hi CD38hi CD19? B cells was
recorded.
CD3 stimulation of PBMCs to induce IL10
production by CD19?CD24hiCD38hi B cells
96 well microtitre plates with round bottom wells
(Sarstedt Ltd, Leicester, UK) were coated with anti-
CD3 mAb (BD Biosciences) at a concentration of
0.5 lg/ml for 1 h at 37 C. Isolated PBMCs were
plated at 25 9 104 cells/well for 72 h at 37 C in a
humidified atmosphere of 5 % CO2 and Brefeldin A
(10 lg/ml; Sigma-Aldrich) was added during the last
6 h of the incubation. After culturing cells with
stimulus they were washed and stained for a combi-
nation of extracellular surface markers to identify
IL10 producing CD24hi CD38hi CD19? B cells. Post
immunostaining, cells were fixed, permeabilised and
stained with anti-human Alexa fluor 647 IL10 anti-
body (described in ‘‘Stimulation of PBMCs to induce
IL10 production by CD4 T cells’’ section). Post
immunostaining, cells were washed and resuspended
in PBS and analysed on a Cyan TM ADP (Dako Ltd,
UK). The percentage of IL10?CD24hi CD38hi CD19?
B cells and IL10 expression levels (MFI value) by
CD24hi CD38hi CD19? B cells was recorded.
T cell independent (LPS) stimulation of PBMCs to
induce IL10 production by CD19?CD24hiCD38hi
B cells
Isolated PBMCs were plated at 25 9 104 cells/well in
a 96 well microtitre plates with round bottom wells
(Sarstedt Ltd, UK) in the presence of LPS isolated
from Escherichia coli serotype 0111:B4 (1 lg/ml;
Peprotech, UK) for 72 h at 37 C in a humidified
atmosphere of 5 % CO2. Brefeldin A (10 lg/ml;
Sigma-Aldrich, UK) was added during the last 6 h of
the incubation. After culturing cells with stimulus they
were washed and stained for a combination of
extracellular surface markers to identify IL10 produc-
ing CD24hi CD38hi CD19? B cells. Post immunos-
taining, cells were fixed, permeabilised and stained
with anti-human Alexa fluor 647 IL10 antibody
(described in ‘‘Stimulation of PBMCs to induce IL10
production by CD4 T cells’’ section). Post immunos-
taining, cells were washed and resuspended in PBS
and analysed on a Cyan TM ADP (Dako Ltd, UK). The
percentage of IL10? CD24hi CD38hi CD19? B cells
and IL10 expression levels (MFI value) by CD24hi
CD38hi CD19? B cells was recorded.
Serum cortisol assay
Serum cortisol levels were measured by ELISA using
a commercial kit (IBL international, Hamburg, Ger-
many) according to manufacturer’s instructions. Intra
assay coefficients of variation (CV %) were 6.7.
Statistical analysis
Univariate ANOVA with least significant difference
post hoc tests were used to assess differences between
the three groups (hip fracture with depressive symp-
toms, hip fracture without depressive symptoms and
healthy controls). Where demographic variables dif-
fered significantly between the three groups analyses
were rerun adjusting for these variables using
ANCOVA. Pearson’s correlations were used to exam-
ine associations between depression score, serum
cortisol levels and T and B cell phenotype and IL10
production.
Results
The demographic details of the study participants have
been reported in full previously (Phillips et al. 2013).
Regulatory T cells in hip fracture patients
Tregs have been defined by the expression of CD4,
CD25 and the transcription factor foxp3 (Buckner
2010; O’Garra and Vieira 2004). On examining the
circulating frequency of CD4?CD25? Foxp3? T cells
no significant differences were observed between hip
fracture patients with and without depressive symp-
toms and healthy older adults, F(2, 57) = 1.24,
p = .29, g2 = .04 (Fig. 1a). Similarly, no significant
differences were found between absolute numbers of
regulatory T cells, F (2, 31) = .98, p = .38, g2 = 06
(Fig. 1b) between our three subject groups.
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IL10 production by CD4 T cells in hip fracture
patients
IL10 secretion is one of the main mechanisms of
immunosuppression used by Tregs (Roncarolo et al.
2006). In this study, IL10 production by CD4 T cells
upon stimulation with PMA and Ionomycin was
measured. Significant differences were seen in the
percentage of IL10 producing CD4 T cells between
our three groups, F (2, 50) = 4.93, p = .01, g2 = .16
(Fig. 2a), driven by a significant increase in the
percentage of IL10? CD4 T cells in hip fracture
patients with depressive symptoms compared with hip
fracture patients without depressive symptoms,
p = .04 and healthy controls, p = .02. No significant
differences were observed in the amount of IL10
expressed (MFI value) by CD4 T cells between our
groups, F(2, 42) = .46, p = .63, g2 = .02 (Fig. 2b).
Interestingly, there was a significant association
between GDS scores and the frequency of peripheral
IL10? CD4 T cells in hip fracture patients, b = .34,
p = .04, DR2 = .11, such that hip fracture patients
with greater depressive symptoms (GDS score) had a
higher frequency of IL10? CD4 T cells (Fig. 2c).
Frequency of CD19? CD24hi CD38hi B cells in hip
fracture patients
Three major populations of circulating B cells have
been reported in peripheral blood: transitional, circu-
lating mature naı¨ve and memory B cells discriminated
on the basis of relative distribution of developmentally
regulated markers CD24 and CD38 (Sims et al. 2005).
The gating strategy used to identify CD19? CD24hi
CD38hi B cells has been reported previously (Duggal
et al. 2013b). On assessing the peripheral frequency
and absolute numbers of B cells no differences were
observed between hip fracture patients with and
without depression and healthy controls (data not
shown), which is in agreement with other reports of
unaltered circulating B cell numbers in depressed
individuals (Basterzi et al. 2010). However the
frequency of CD19?CD24hiCD38hi B cells in the B
cell pool differed between our three groups, F(2,
61) = 11.16, p\ .001, g2 = .26 (Fig. 3a), due to a
decline in this subset in hip fracture patients with
depressive symptoms compared with healthy controls,
p\ .001 as well as hip fracture patients without
depressive symptoms, p = .001. When all of the
above analyses were repeated with adjustment for age,
sex and BMI, the results still remained significant
(data not shown).
Similarly, significant differences were seen in
absolute numbers of CD19?CD24hiCD38hi B cells, F
(2, 38) = 4.85, p = .01, g2 = .20 (Fig. 3b) between
our three groups, driven by a significant decline in
absolute numbers in hip fracture patients with depres-
sive symptoms compared with healthy controls,
p = .04 as well as hip fracture patients without
depressive symptoms, p = .02. A significant associ-
ation was observed between GDS scores and fre-
quency of peripheral CD19?CD24hiCD38hi B cells in
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Fig. 1 CD4? CD25? Foxp3? regulatory T lymphocytes in hip
fracture patients. a Percentage of CD4? CD25? Foxp3? T cells
in healthy controls (n = 20), hip fracture patients without
depressive symptoms (HF; n = 20) and hip fracture patients
with depressive symptoms (HF ? D; n = 20). The solid bar
represents the mean value. b Absolute number of CD4? CD25?
Foxp3? regulatory T cells in healthy controls (n = 12), hip
fracture patients without depressive symptoms (HF; n = 13)
and hip fracture patients with depressive symptoms (HF ? D;
n = 10). Data are mean ± SEM
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CD19?CD24hiCD38hi B
cells in hip fracture patients.
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in healthy controls (n = 21),
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hip fracture patients, b = -0.38, p = 0.01,
DR2 = 0.15, such that hip fracture patients with
greater depressive symptoms (GDS score) had lower
frequency of CD19?CD24hiCD38hi B cells (Fig. 3c).
IL10 production by CD19? CD24hi CD38hi B cells
in hip fracture patients
The hallmark of CD19? CD24hi CD38hi B cell
suppressive function is their ability to produce IL10
(Vitale et al. 2010). CD40 is a co-stimulatory molecule
known to be involved in T cell mediated B cell
activation (Castigli et al. 1994) known to upregulate
IL10 production (Mauri et al. 2003). We have
previously reported that CD19? CD24hi CD38hi B
cells are the main IL10 producing B cell subset post
CD40 stimulation (Duggal et al. 2013b). Thus, the
frequency of IL10 producing CD19?CD24hiCD38hi B
cells post CD3 stimulation (72 h) was determined. The
data revealed significant differences between our
groups, F (2, 55) = 4.88, p = .01, g2 = .15, but the
reduction in IL10 induction was restricted to hip
fracture patients with depressive symptoms compared
with healthy controls, p = .04 and hip fracture
patients without depression, p = .01 (Fig. 4a). When
all of the above analyses were repeated with adjust-
ment for age, sex and BMI, the results still remained
significant (data not shown). However, the mean IL10
production by CD19?CD24hiCD38hi B cells post
stimulation did not differ between the subject groups,
F(2, 55) = 0.85, p = 0.43, g2 = 0.03 (Fig. 4b).
There was a significant association between GDS
scores and the frequency of IL10 producing CD19?-
CD24hiCD38hi B cells post stimulation in hip fracture
patients, b = -0.34, p = .03, DR2 = 0.34, such that
hip fracture patients with greater depressive symptoms
(GDS score) had a lower frequency of CD19?CD24hi-
CD38hi B cells (Fig. 4c).
In addition to T cell-dependent stimulation, B cells
can also be activated by microbial products via Toll-
like receptor (TLR) signalling (Yanaba et al. 2009). In
a previous study we showed that CD19? CD24hi
CD38hi B cells are the main IL10 producing B cell
subset post TLR4 ligand (LPS) stimulation (Duggal
et al 2013b). On examining IL10 production by
CD19? CD24hi CD38hi B cells on stimulation by
LPS no significant differences were observed between
our groups, F(2, 41) = 2.03, p = .14, g2 = .43
(Fig. 4d), although a trend towards a decline in IL10
production by Bregs was observed in hip fracture
patients with depressive symptoms.
Serum cortisol and regulatory immune cell
parameters
We have previously reported elevated serum cortisol
levels in the hip fracture patients with depressive
symptoms compared with patients with hip fracture
alone and healthy controls []. However, there was no
significant association between serum cortisol levels
and IL10 producing CD4 T cells in hip fracture
patients, b = -0.10, p = 0.49, DR2 = 0.02 (Fig. 5a).
Further, there was no significant association between
serum cortisol levels and IL10 producing CD19?-
CD24hiCD38hi B cells in hip fracture patients,
b = -0.15, p = 0.28, DR2 = 0.02 (Fig. 5b). When
all of the above analyses were repeated with adjust-
ment for age and BMI, the results remained the same.
Discussion
A high incidence of depression has been observed
after hip fracture by many studies and was seen in
approximately one-third of our hip fracture patients at
6 weeks post-surgery, which is consistent with previ-
ous studies (Holmes and House 2000; Lenze et al.
2007). Although mood disorders, especially depres-
sion, have been well studied in older patients with
fractured neck of femur (Holmes and House 2000;
Lenze et al. 2007), the effects of depressive symptoms
on immune functioning are less well studied or
appreciated in the clinical context. We have recently
published that neutrophil bactericidal properties (Dug-
gal et al. 2013a), monocyte (Duggal et al. 2014) and
NK cell functioning (Duggal et al. 2015) are impaired
only in those hip fracture patients that developed
depressive symptoms. We have also shown that new
onset of depressive symptoms is associated with poor
physical recovery after hip fracture (Phillips et al.
2013). Here we have now shown the effects of chronic
stress (hip fracture and depression) on two regulatory
immune cell subsets; CD4?CD25?Foxp3? (Tregs) and
CD19?CD24hiCD38hi (Bregs) and again find that
depressive symptoms are the factor determining the
immune alterations.
Firstly, on examining the effect of hip fracture and
depressive symptomsonTregs, no significant differences
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were observed in the frequency of circulating CD4?
CD25?Foxp3? Tregs, which contradicts the findings of
two previous studies showing a decline in Tregs in mice
with depression-like behaviour (Kim et al. 2012) and in
humans with major depression (Li et al. 2010).
Furthermore, another study has shown that anti-depres-
sant therapy increased Treg numbers and this was
associated with a reduction in depression and reduced
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Fig. 4 IL10 production by CD19?CD24hiCD38hi B cells in hip
fracture patients. a Frequency of IL10?CD19?CD24hiCD38hi
cells in healthy controls (n = 18), hip fracture patients without
depressive symptoms (HF; n = 21) or hip fracture patients with
depressive symptoms (HF?D; n = 19). The solid bar repre-
sents the mean value. b IL10 production by CD19?CD24hi-
CD38hi cells in healthy controls (n = 18), hip fracture patients
without depressive symptoms (HF; n = 21) or hip fracture
patients with depressive symptoms (HF?D; n = 19) post CD3
stimulation for 72 h. Data are mean ± SEM. c Correlation
between percentage of IL10?CD19?CD24hiCD38hi B cells post
CD3 stimulation (72 h) and GDS scores in hip fracture patients
(n = 40). d IL10 production by CD19?CD24hiCD38hi cells in
healthy controls (n = 24), hip fracture patients without depres-
sive symptoms (HF; n = 26) or hip fracture patients with
depressive symptoms (HF?D; n = 22) post LPS stimulation for
72 h. *p\ 0.05
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serum pro-inflammatory cytokines which have a role in
the pathophysiology of depression (Himmerich et al.
2010). One possible explanation of this contradiction
might beheterogeneity inTreg characterisation, the three
previous studies classifiedCD4?CD25?Tcells asTregs,
rather than the more accurate CD4? CD25? Foxp3?
phenotype and many of these cells would have been
CD25 expressing activated T cells rather than Foxp3
expressing immunosuppressive Tregs. The regulatory
function of Tregs is known to be mediated via immuno-
suppressive cytokines such as IL10 (Vignali et al. 2008).
IL10 is an immunoregulatory cytokine that plays a
central role in controlling inflammation by suppressing
T cell proliferation and cytokine production, antigen
presentation and proinflammatory cytokine production
by monocytes (Moore et al. 2001). We have previously
reported higher circulating levels of IL10 in hip
fracture patients with new onset of depression
(22.41 ± 6.46 pg/ml) compared with hip fracture
patients without depression (10.37 ± 2.25 pg/ml) or
healthy controls (5.27 ± 1.11 pg/ml) (Duggal et al.
2013a) and here we show a marked increase in IL10
production by CD4 T cells of hip fracture patients with
depressive symptoms compared to healthy controls.
These data suggest that this is likely to account for the
raised IL10 seen in these patients and may contribute to
the reduced function of a variety of immune cells seen
after hip fracture. Interestingly, a significant positive
association was also found between GDS scores and
IL10 production by CD4 T cells. Although this is the
first study to examine the effect of hip fracture and
depression on IL10 production by CD4? T cells, a few
studies examining the effect of chronic stress such as
caregiving (Damjanovic et al. 2007; Glaser et al. 2001)
and academic stress (Koh et al. 2008) have reported
increased IL10 production and secretion. Whether the
raised IL10 production is a response to the inflammation
associated with depression in our cohort, we found
raised IL6 and TNFa only in the hip fracture patients
who developed depressive symptoms (Duggal et al.
2013a), remains to be shown but is one possibility. HPA
axis hyperactivity is one of themost recognised findings
in depressed patients (Gold et al. 1988). In-vitro studies
have shown that glucocorticoids enhance IL10 produc-
tion by CD4 T cells (Franchimont 2004; Richards et al.
2000). We have previously reported elevated serum
cortisol levels in hip fracture patients with depressive
symptoms (Duggal et al. 2013a). However, we failed to
find any association between frequency of IL10?CD4T
cells and serum cortisol levels in hip fracture patients.
Recently Bregs have attracted increasing attention
for the important role of these cells in maintaining
immune homeostasis. Studies on Bregs in humans are
still limited and our study is the first to examine the
effects of ageing and chronic stress on these immuno-
suppressive cells. We have previously reported a
numerical deficit in CD19?CD24hiCD38hi B cells
with advancing age. In this study on examining the
additive effect of chronic stress on this age associated
numerical deficit we report a further reduction in the
frequency of Bregs (CD19
?CD24hiCD38hi) in hip
fracture patients with depressive symptoms. In addi-
tion we also found impairments in immunosuppressive
properties of these cells with age (Duggal et al. 2013b)
and here we show an additional decline in IL10
production upon CD3 stimulation in hip fracture
patients with depressive symptoms. Again to the best
of our knowledge this is the first study to examine the
effect of psychological stress on IL10 production by B
cells. However, these data are surprising when
considered together with the increased IL10 produc-
tion by CD4 T cells shown here and the overall raised
serum IL10 reported in these patients previously
(Duggal et al. 2013a). Although the effect of gluco-
corticoids on Bregs remains unexplored, we failed to
find any association between frequencies of IL10?
Bregs and serum cortisol levels in hip fracture patients.
From these data we have to conclude that the
increased frequency and function of the Treg popula-
tion dominates in these patients and contributes to the
reduced function seen in a variety of immune cells in
these patients (Duggal et al. 2013a, 2015).
Conclusion
In conclusion, the present study reports for the first time
that development of new onset depressive symptoms in
older hip fracture patients results in numerical and
functional deficits in Bregs but an increase in IL10
production by CD4 T cells. These findings suggest that
impairments in T regulatory immune cells might be a
contributing factor towards immune suppression in hip
fracture patients with depressive symptoms and our
data support the need for early prevention and treatment
of depression in older hip fracture patients.
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